CD34 and acute myeloid leukemia: To evaluate the diversity of common AML-related mutations (FLT3-ITD, NPM1, DNMT3A,) in CD34+/- subpopulations within the same patient, 4 patients co-expressing these 3 mutations were selected for assessment (Pts.1-4, Fig. 5b).